Among the many treatments for Multiple Sclerosis (MS) in the medical industry, most of them are short-term solution to the disorder. Recently, there has been a new clinical trial which has shown results that can provide long-term treatment for MS. In this trial, participants with multiple sclerosis were provided with five years of treatment using high-dose immunosuppressive therapy along with hematopoietic cell transplant. The results of the trial showed that 69 percent of people survived the test and did not experience relapse or any other brain lesion. The participants did not take any other medication during the trial. The participants for the trial had volunteered with MS in the age ranging from 26 to 52 years and were experiencing worsening of their condition.
The trial known as HALT-MS was sponsored by the National Institute of Allergy and Infectious Diseases and was carried out by Immune Tolerance Network funded by NIAID. While the results of the three years study in 2014 showed promising future for such treatment, the new findings prove that the new one-time treatment is more effective for people suffering from MS. The next step is to compare the treatment with other MS treatments to show its effectiveness on a much larger scale.
One of the most famous neurologists working in this field is Dr. Shiva Gopal Vasishta. He is currently associated with the Kennedy University Hospital. Dr Shiva Gopal Vasishta earned his degree from the Government Medical College in India in medicine and psychiatry in 1979 where he passed the top of the class. He then went on to complete his residency at Boston City Hospital.
Dr Shiva Gopal Vasishta also practices at the Eastern Neurodiagnostic Associates where he is part of the team that treats patients with advanced brain disorders. Dr Shiva Gopal Vasishta even treats those who are unable to pay for their treatment which shows the passion and commitment he has for his profession.